Category: clinical study retractions

Journal retracts stem cell study despite objections of most authors

Gerold Feuer in 2008, via Upstate
Gerold Feuer in 2008, via Upstate

The journal Blood has retracted a 2010 paper over the objections of most of its authors, two of whom were found by their university to have used “fraudulent methods” to obtain the data.

We first reported on the case of Gerold Feuer last fall. The State University of New York (SUNY) Upstate Medical Center in Syracuse fired Feuer in 2010 after determining that he had misused state funds to enrich a company he had founded, HuMurine. A court agreed with many of the university’s claims, but ordered his reinstatement in 2012.

Meanwhile, as we noted last fall: Continue reading Journal retracts stem cell study despite objections of most authors

Pfizer retracts another experimental cancer drug study

clin cancer researchPfizer has retracted another study involving an experimental cancer drug that later failed later-stage trials.

The study, published in Clinical Cancer Research in 2010, looked at which patients might respond to the drug, called figitumumab. Here’s the notice: Continue reading Pfizer retracts another experimental cancer drug study

Authors plagiarize CME cancer article, lose their review paper

or_miniOncology Reviews has retracted a 2014 paper on breast cancer after learning that the authors lifted parts of it from a continuing medical education lesson on Medscape.

The paper, “Challenges of combined everolimus/endocrine therapy in hormone receptor-positive metastatic breast cancer,” was written by Yousif Abubakr, of Thomas Jefferson University in Philadelphia, and Yasar Albushra, of King Faisal Specialist Hospital & Research Centre, in Saudi Arabia.

According to the retraction notice: Continue reading Authors plagiarize CME cancer article, lose their review paper

Researchers retract breast cancer study after realizing they were using the wrong antibody

br j cancerA group of researchers at Istanbul University has swiftly retracted a paper they published in March in the British Journal of Cancer once it became clear that they were using the wrong antibody.

Here’s the notice for “Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies:” Continue reading Researchers retract breast cancer study after realizing they were using the wrong antibody

UT-Southwestern cancer researchers up to 8 retractions

oncogeneA group at the University of Texas Southwestern led by Adi F. Gazdar that found evidence of inappropriate image manipulation in a number of their papers has retracted its seventh and eighth studies.

Here’s the notice for 2005’s “Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection,” in Oncogene: Continue reading UT-Southwestern cancer researchers up to 8 retractions

JCI retracts 10-year-old cancer study because figures were “intentionally mislabeled”

jci june 14The Journal of Clinical Investigation is retracting a 2004 paper by a cancer researchers from Italy because of “evident misrepresentation of data and image duplication.”

Here’s the notice for “The IL-12Rβ2 gene functions as a tumor suppressor in human B cell malignancies:” Continue reading JCI retracts 10-year-old cancer study because figures were “intentionally mislabeled”

Plagiarism spells demise of complementary medicine paper

JEBCAMThe Journal of Evidence-Based Complementary Medicine (JEBCAM) has retracted a 2013 review on probiotics by an author from Turkey who patched the paper together from a variety of other sources — and then appears to have reused his own work elsewhere without attribution.

The article was written by Öner Özdemir, a pediatric allergy specialist at İstanbul Medeniyet University. According to the abstract: Continue reading Plagiarism spells demise of complementary medicine paper

Duck, duck, gone: Duplication plucks bird flu paper

zoonoses and public healthIf it looks like a duck flu study, and quacks like a duck flu study, and it’s word-for-word the same as a duck flu study…

Zoonoses and Public Health has retracted a 2013 paper on bird flu in Myanmar because the authors had published the article previously in a different journal.

The article, “Risks of Avian Influenza (H5) in Duck Farms in the Ayeyarwaddy Delta Region, Myanmar,” was written by a group led by Alongkorn Amonsin, of the Department of Veterinary Public Health at Chulalongkorn University, in Bangkok, Thailand.

Per the abstract: Continue reading Duck, duck, gone: Duplication plucks bird flu paper

Editor in chief steps down after being found plagiarizing in her own journal

diab met syndImagine you were a cop, sitting in your squad car at the side of the road with a radar gun, when you clock someone speeding. You turn on your lights, pull the speedster over to the side of the road, and walk to her driver’s side window.

Just as you say “Driver’s license and registration, please,” you realize the driver is your squad captain. Oops.

That must have been something like what it was like — with plagiarism detection software sitting in for the radar gun — for the co-editor-in-chief of Diabetology & Metabolic Syndrome when he realized that Marilia de Brito Gomes, the other co-editor-in-chief, had published two papers in their journal that contained plagiarized passages.

Here’s the notice for “Historical facts of screening and diagnosing diabetes in pregnancy:” Continue reading Editor in chief steps down after being found plagiarizing in her own journal

Cancer researcher who threatened to sue Retraction Watch corrects another paper

aggarwalBharat Aggarwal, the MD Anderson researcher who has threatened to sue Retraction Watch for writing about issues in his papers, has corrected another study.

Here’s the notice for “Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-κB Mutations or Activation of the CD30, CD40, and RANK Receptors:” Continue reading Cancer researcher who threatened to sue Retraction Watch corrects another paper